Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis
Clinical trial NCT02335255 · COMPLETED
Trial details
- NCT number
- NCT02335255
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-27
- Primary completion
- 2018-05-15
- Enrollment
- 1519
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.